Advertisement

Topics

PTC Therapeutics to commercialise Akcea’s two rare disease drugs

19:00 EDT 2 Aug 2018 | Pharmaceutical Technology

Ionis Pharmaceuticals affiliate Akcea Therapeutics has signed an agreement with biopharmaceutical company PTC Therapeutics for the commercialisation of its rare...
Read More...

The post PTC Therapeutics to commercialise Akcea’s two rare disease drugs appeared first on Pharmaceutical Technology.

Original Article: PTC Therapeutics to commercialise Akcea’s two rare disease drugs

NEXT ARTICLE

More From BioPortfolio on "PTC Therapeutics to commercialise Akcea’s two rare disease drugs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...